Advanced search
1 file | 1.31 MB Add to list

2013 ESH/ESC Guidelines for the management of arterial hypertension

(2013) BLOOD PRESSURE. 22(4). p.193-278
Author
Organization
Abstract
Because of new evidence on several diagnostic and therapeutic aspects of hypertension, the present guidelines differ in many respects from the previous ones. Some of the most important differences are listed below: 1. Epidemiological data on hypertension and BP control in Europe. 2. Strengthening of the prognostic value of home blood pressure monitoring (HBPM) and of its role for diagnosis and management of hypertension, next to ambulatory blood pressure monitoring (ABPM). 3. Update of the prognostic significance of night-time BP, white-coat hypertension and masked hypertension. 4. Re-emphasis on integration of BP, cardiovascular (CV) risk factors, asymptomatic organ damage (OD) and clinical complications for total CV risk assessment. 5. Update of the prognostic significance of asymptomatic OD, including heart, blood vessels, kidney, eye and brain. 6. Reconsideration of the risk of overweight and target body mass index (BMI) in hypertension. 7. Hypertension in young people. 8. Initiation of antihypertensive treatment. More evidence-based criteria and no drug treatment of high normal BP. 9. Target BP for treatment. More evidence-based criteria and unified target systolic blood pressure (SBP) (<140 mmHg) in both higher and lower CV risk patients. 10. Liberal approach to initial monotherapy, without any all-ranking purpose. 11. Revised schema for priorital two-drug combinations. 12. New therapeutic algorithms for achieving target BP. 13. Extended section on therapeutic strategies inspecial conditions. 14. Revised recommendations on treatment of hypertensionin the elderly. 15. Drug treatment of octogenarians. 16. Special attention to resistant hypertension and newtreatment approaches. 17. Increased attention to OD-guided therapy. 18. New approaches to chronic management of hypertensive disease.
Keywords
guidelines, CORONARY-HEART-DISEASE, follow-up, device therapy, cardiovascular risk, cardiovascular complications, blood pressure measurement, blood pressure, antihypertensive treatment, hypertension, lifestyle, organ damage, RANDOMIZED CONTROLLED-TRIAL, AMBULATORY BLOOD-PRESSURE, CHRONIC KIDNEY-DISEASE, ISOLATED SYSTOLIC HYPERTENSION, RENAL SYMPATHETIC DENERVATION, LEFT-VENTRICULAR HYPERTROPHY, INTIMA-MEDIA THICKNESS, OBSTRUCTIVE SLEEP-APNEA, CARDIOVASCULAR RISK-FACTORS

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 1.31 MB

Citation

Please use this url to cite or link to this publication:

MLA
Mancia, Giuseppe, Robert Fagard, Krzysztof Narkiewicz, et al. “2013 ESH/ESC Guidelines for the Management of Arterial Hypertension.” BLOOD PRESSURE 22.4 (2013): 193–278. Print.
APA
Mancia, Giuseppe, Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T., et al. (2013). 2013 ESH/ESC Guidelines for the management of arterial hypertension. BLOOD PRESSURE, 22(4), 193–278.
Chicago author-date
Mancia, Giuseppe, Robert Fagard, Krzysztof Narkiewicz, Josep Redón, Alberto Zanchetti, Michael Böhm, Thierry Christiaens, et al. 2013. “2013 ESH/ESC Guidelines for the Management of Arterial Hypertension.” Blood Pressure 22 (4): 193–278.
Chicago author-date (all authors)
Mancia, Giuseppe, Robert Fagard, Krzysztof Narkiewicz, Josep Redón, Alberto Zanchetti, Michael Böhm, Thierry Christiaens, Renata Cifkova, Gui De Backer, Anna Dominiczak, Maurizio Galderisi, Diederick E Grobbee, Tiny Jaarsma, Paulus Kirchhof, Sverre E Kjeldsen, Stéphane Laurent, Athanasios J Manolis, Peter M Nilsson, Luis Miguel Ruilope, Roland E Schmieder, Per Anton Sirnes, Peter Sleight, Margus Viigimaa, Bernard Waeber, Faiez Zannad, Anna Dominiczak, Michel Burnier, Ettore Ambrosioni, Mark Caufield, Antonio Coca, Michael Hecht Olsen, Roland E Schmieder, Costas Tsioufis, Philippe van de Borne, Jose Luis Zamorano, Stephan Achenbach, Helmut Baumgartner, Jeroen J Bax, Héctor Bueno, Veronica Dean, Christi Deaton, Cetin Erol, Roberto Ferrari, David Hasdai, Arno W Hoes, Paulus Kirchhof, Juhani Knuuti, Philippe Kolh, Patrizio Lancellotti, Ales Linhart, Petros Nihoyannopoulos, Massimo F Piepoli, Piotr Ponikowski, Juan Luis Tamargo, Michal Tendera, Adam Torbicki, William Wijns, Stephan Windecker, Denis Clement, Thierry Gillebert, Enrico Agabiti Rosei, Stefan D Anker, Johann Bauersachs, Jana Brguljan Hitij, Marc De Buyzere, Sabina De Geest, Geneviève Anne Derumeaux, Serap Erdine, Csaba Farsang, Christian Funck-Brentano, Vjekoslav Gerc, Giuseppe Germano, Stephan Gielen, Herman Haller, Jens Jordan, Thomas Kahan, Michel Komajda, Dragan Lovic, Heiko Mahrholdt, Jan Ostergren, Gianfranco Parati, Joep Perk, Jorge Polonia, Bogdan A Popescu, Željko Reiner, Lars Rydén, Yuriy Sirenko, Alice Stanton, Harry Struijker-Boudier, Charalambos Vlachopoulos, Massimo Volpe, and David A Wood. 2013. “2013 ESH/ESC Guidelines for the Management of Arterial Hypertension.” Blood Pressure 22 (4): 193–278.
Vancouver
1.
Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension. BLOOD PRESSURE. 2013;22(4):193–278.
IEEE
[1]
G. Mancia et al., “2013 ESH/ESC Guidelines for the management of arterial hypertension,” BLOOD PRESSURE, vol. 22, no. 4, pp. 193–278, 2013.
@article{4084270,
  abstract     = {Because of new evidence on several diagnostic and therapeutic aspects of hypertension, the present guidelines differ in many respects from the previous ones. Some of the most important differences are listed below: 
1. Epidemiological data on hypertension and BP control in Europe. 
2. Strengthening of the prognostic value of home blood pressure monitoring (HBPM) and of its role for diagnosis and management of hypertension, next to ambulatory blood pressure monitoring (ABPM). 
3. Update of the prognostic significance of night-time BP, white-coat hypertension and masked hypertension. 
4. Re-emphasis on integration of BP, cardiovascular (CV) risk factors, asymptomatic organ damage (OD) and clinical complications for total CV risk assessment. 
5. Update of the prognostic significance of asymptomatic OD, including heart, blood vessels, kidney, eye and brain. 
6. Reconsideration of the risk of overweight and target body mass index (BMI) in hypertension. 
7. Hypertension in young people. 
8. Initiation of antihypertensive treatment. More evidence-based criteria and no drug treatment of high normal BP. 
9. Target BP for treatment. More evidence-based criteria and unified target systolic blood pressure (SBP) (<140 mmHg) in both higher and lower CV risk patients. 
10. Liberal approach to initial monotherapy, without any all-ranking purpose. 
11. Revised schema for priorital two-drug combinations. 
12. New therapeutic algorithms for achieving target BP. 
13. Extended section on therapeutic strategies inspecial conditions. 
14. Revised recommendations on treatment of hypertensionin the elderly. 
15. Drug treatment of octogenarians. 
16. Special attention to resistant hypertension and newtreatment approaches. 
17. Increased attention to OD-guided therapy. 
18. New approaches to chronic management of hypertensive disease.},
  author       = {Mancia, Giuseppe and Fagard, Robert and Narkiewicz, Krzysztof and Redón, Josep and Zanchetti, Alberto and Böhm, Michael and Christiaens, Thierry and Cifkova, Renata and De Backer, Gui and Dominiczak, Anna and Galderisi, Maurizio and Grobbee, Diederick E and Jaarsma, Tiny and Kirchhof, Paulus and Kjeldsen, Sverre E and Laurent, Stéphane and Manolis, Athanasios J and Nilsson, Peter M and Ruilope, Luis Miguel and Schmieder, Roland E and Sirnes, Per Anton and Sleight, Peter and Viigimaa, Margus and Waeber, Bernard and Zannad, Faiez and Dominiczak, Anna and Burnier, Michel and Ambrosioni, Ettore and Caufield, Mark and Coca, Antonio and Olsen, Michael Hecht and Schmieder, Roland E and Tsioufis, Costas and van de Borne, Philippe and Zamorano, Jose Luis and Achenbach, Stephan and Baumgartner, Helmut and Bax, Jeroen J and Bueno, Héctor and Dean, Veronica and Deaton, Christi and Erol, Cetin and Ferrari, Roberto and Hasdai, David and Hoes, Arno W and Kirchhof, Paulus and Knuuti, Juhani and Kolh, Philippe and Lancellotti, Patrizio and Linhart, Ales and Nihoyannopoulos, Petros and Piepoli, Massimo F and Ponikowski, Piotr and Tamargo, Juan Luis and Tendera, Michal and Torbicki, Adam and Wijns, William and Windecker, Stephan and Clement, Denis and Gillebert, Thierry and Rosei, Enrico Agabiti and Anker, Stefan D and Bauersachs, Johann and Hitij, Jana Brguljan and De Buyzere, Marc and De Geest, Sabina and Derumeaux, Geneviève Anne and Erdine, Serap and Farsang, Csaba and Funck-Brentano, Christian and Gerc, Vjekoslav and Germano, Giuseppe and Gielen, Stephan and Haller, Herman and Jordan, Jens and Kahan, Thomas and Komajda, Michel and Lovic, Dragan and Mahrholdt, Heiko and Ostergren, Jan and Parati, Gianfranco and Perk, Joep and Polonia, Jorge and Popescu, Bogdan A and Reiner, Željko and Rydén, Lars and Sirenko, Yuriy and Stanton, Alice and Struijker-Boudier, Harry and Vlachopoulos, Charalambos and Volpe, Massimo and Wood, David A},
  issn         = {0803-7051},
  journal      = {BLOOD PRESSURE},
  keywords     = {guidelines,CORONARY-HEART-DISEASE,follow-up,device therapy,cardiovascular risk,cardiovascular complications,blood pressure measurement,blood pressure,antihypertensive treatment,hypertension,lifestyle,organ damage,RANDOMIZED CONTROLLED-TRIAL,AMBULATORY BLOOD-PRESSURE,CHRONIC KIDNEY-DISEASE,ISOLATED SYSTOLIC HYPERTENSION,RENAL SYMPATHETIC DENERVATION,LEFT-VENTRICULAR HYPERTROPHY,INTIMA-MEDIA THICKNESS,OBSTRUCTIVE SLEEP-APNEA,CARDIOVASCULAR RISK-FACTORS},
  language     = {eng},
  number       = {4},
  pages        = {193--278},
  title        = {2013 ESH/ESC Guidelines for the management of arterial hypertension},
  url          = {http://dx.doi.org/10.3109/08037051.2013.812549},
  volume       = {22},
  year         = {2013},
}

Altmetric
View in Altmetric
Web of Science
Times cited: